Stock 300434 SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Sichuan Goldstone Asia Pharmaceutical Inc.

Equities

300434

CNE100001YX5

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-06-13 pm EDT 		5-day change 1st Jan Change
7.86 CNY -0.76% Intraday chart for Sichuan Goldstone Asia Pharmaceutical Inc. +1.03% -28.93%
Apr. 25 Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Hangzhou Solipharma Technology Development Co., Ltd. announced that it expects to receive CNY 69.4857 million in funding from Sichuan Goldstone Asia Pharmaceutical Inc., Hangzhou Huolongguo Investment Management Co., Ltd. and another investor CI
809e471.Bj6LY6vgS1GU3UTqn0F2gFiypO7DX4-_Jov0bURZrkE.bHqyVOPUAg7NsiWy3QU3xwyHk5SBa-TRRbK4Iws05gNObMwn_NYaG9eLcA~8939338d7f54425b411046887600557b
  1. Stock Market
  2. Equities
  3. 300434 Stock
  4. Charts Sichuan Goldstone Asia Pharmaceutical Inc.
  5. News Chart